Please assess the completion status of the following clinical trial:

Trial Title: Assessment of Probiotics Lactobacillus in the Management of Attention Deficit Hyperactive Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age from 6 to 16 years old.~* Children fulfilled DSM(V) Criteria for ADHD syndrome.~Exclusion Criteria:~* Intelligence quotient (IQ) less than 80% .~* Presence of other medical conditions as chronic medical or neuropsychiatric disorders e.g diabetes mellitus, epilepsy.....etc. hearing or visual impairment, or medications side effects.~* currently taking probiotics or antibiotics

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 16 Years
- Healthy Volunteers: t

Study Arms:
- Patient with attention deficit hyperactive disorser (Type: ACTIVE_COMPARATOR): patients (n=40) will receive probiotic preparation twice daily (Lacteol Forte; Rameda, Egypt) as sachets containing 10 billion colony forming units (CFU) of Lactobacillus fermentum and Lactobacillus delbruekii for 12 weeks added to standard treatment
- ADHD not receiving probiotics (Type: NO_INTERVENTION): ADHD patient (40) on standard treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).